Delivery Order SPE2DB20D2014-SPE2DB24FD01W
Award Date
9/12/24
Potential Completion Date
9/13/24
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,007.70, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a Delivery Order contract with a Firm Fixed Price pricing type, and an ultimate completion date of February 19, 2025. The contract covers the procurement of 4567304287 units of Methylergonovine 0.2 mg/ml, a medication used to treat certain postpartum conditions. AmerisourceBergen holds a larger...
This is a $3,655.04 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,566,451,243 units of the drug methylergonovine 0.2 mg/ml in 1 ml vials. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,093.12 firm-fixed-price Delivery Order covers the supply of Methylergonovine 0.2 mg/mL injections to support military and government healthcare programs. The contract has a period of performance through February 5, 2024 and was not designated as a set-aside. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999...
This federal contract award is between the Defense Logistics Agency (DLA) and Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,358.52, is for the delivery of methylergonovine 0.2 mg tablets to support military and government healthcare needs. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,567,421,593 units of the pharmaceutical product Methylergonovine 0.2 mg Tablet. The $1,087.01 firm fixed-price contract has an ultimate completion date of March 3, 2025. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award, valued at $1,859.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567118669 - Methylergonovine 0.2 mg/ml vial. This is a Firm Fixed Price Delivery Order contract with a completion date of February 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,156.84 firm-fixed-price delivery order covers the supply of 4564904974 - METHYLERGONOVINE 0.2 MG/ML VLML, with a period of performance through June 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is for the delivery of 4,566,265 units of Methylergonovine 0.2 mg/ml vials, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The $1,242.55 firm-fixed-price delivery order contract has an ultimate completion date of October 30, 2024. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor and there is no set-aside designation. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4560843660 - Methylergonovine 0.2 mg/ml vials, with a ceiling value of $1,653.27 and a performance period through May 8, 2023. The contract is a firm fixed-price agreement, with no set-aside designation indicated. Amerisourcebergen is the prime contractor, and there is no...
This federal contract award, valued at $2,873.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4560862324 - Methylergonovine 0.2 mg/ml vials, with a performance period ending on May 9, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...